Заходи Охорона здоров'я, фармацевтика Рим, Італія Вересень 2023

The calendar is regularly updated on exhibition venue and event websites or by organizer request. For the latest information, please visit the exhibition website.

Breast cancer is a significant area of cancer research due to its common and deadly nature. The diagnosis and treatment of this disease are driven by biology, requiring a multidisciplinary team of specialists. Effective interventions are available in all stages of the process.

SMi are proud to present their 9th annual Point of Care Diagnostics: Market Opportunities and Technology Trends24th and 25th of October, 2012. With point of care constantly at the forefront of the biotechnology and healthcare markets, the need for up to date information on both the emerging technologies, and the market opportunities is paramount. Rapid testing in all areas of healthcare, from primary care to the emergency services is becoming increasingly expected, and successful point of care technology can revolutionise our ability to create this fast, personalised medicine. Challenges still remain, however, about the logistics of companion diagnostics, the legitimacy of patient independence and the redistribution of profit within the healthcare technology sector. The ultimate question of whether we can create a treatment specific for a patient, rather than a disease necessitates an ability to communicate with key opinion leaders, successful companies and academic leaders within the field, and conferences such as this are an integral part of that process.